Camrelizumab and Apatinib Combined With Chemotherapy (mFOLFOX6) in Neoadjuvant Therapy for Locally Advanced Colon Cancer
Latest Information Update: 19 Jul 2023
At a glance
- Drugs Camrelizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Rivoceranib (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- Acronyms AMBITION
- 14 Jul 2023 Planned primary completion date changed from 30 Mar 2023 to 30 Dec 2024.
- 27 Jan 2023 Planned primary completion date changed from 30 Nov 2022 to 30 Mar 2023.
- 17 Jan 2021 Status changed from not yet recruiting to recruiting.